Skip to main navigation Skip to search Skip to main content

Opioid analgesia and opioid-induced adverse effects: A review

  • Alok K. Paul
  • , Craig M. Smith
  • , Mohammed Rahmatullah
  • , Veeranoot Nissapatorn
  • , Polrat Wilairatana
  • , Mariana Spetea
  • , Nuri Gueven
  • , Nikolas Dietis
  • University of Tasmania
  • Deakin University
  • University of Development Alternative
  • Walailak University
  • University of Innsbruck
  • University of Cyprus

Research output: Contribution to journalReview articlepeer-review

251 Citations (Scopus)

Abstract

Opioids are widely used as therapeutic agents against moderate to severe acute and chronic pain. Still, these classes of analgesic drugs have many potential limitations as they induce analgesic tolerance, addiction and numerous behavioural adverse effects that often result in patient non-compliance. As opium and opioids have been traditionally used as painkillers, the exact mechanisms of their adverse reactions over repeated use are multifactorial and not fully understood. Older adults suffer from cancer and non-cancer chronic pain more than younger adults, due to the physiological changes related to ageing and their reduced metabolic capabilities and thus show an increased number of adverse reactions to opioid drugs. All clinically used opioids are µ-opioid receptor agonists, and the major adverse effects are directly or potentially connected to this receptor. Multifunctional opioid ligands or peripherally restricted opioids may elicit fewer adverse effects, as shown in preclinical studies, but these results need reproducibility from further extensive clinical trials. The current review aims to overview various mechanisms involved in the adverse effects induced by opioids, to provide a better understanding of the underlying pathophysiology and, ultimately, to help develop an effective therapeutic strategy to better manage pain.

Original languageEnglish
Article number1091
JournalPharmaceuticals
Volume14
Issue number11
DOIs
Publication statusPublished - Nov 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Adverse effects
  • Analgesia
  • Behaviour
  • Chronic pain
  • Morphine
  • Opioids
  • Tolerance

Fingerprint

Dive into the research topics of 'Opioid analgesia and opioid-induced adverse effects: A review'. Together they form a unique fingerprint.

Cite this